missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ DL-AP5 Sodium salt
Potent and selective NMDA antagonist; sodium salt of DL-AP5
126.00€ - 464.00€
Specifications
| Purity | >98% |
|---|---|
| Product Type | DL-AP5 Sodium salt |
| Molecular Weight (g/mol) | 219.11 |
| Inhibitors | DL-AP5 Sodium salt |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
18044332
|
Tocris Bioscience™
3693/10 |
10 mg |
126.00€
10mg |
Estimated Shipment: 30-01-2025
Log in to see stock. |
|||||
|
18014962
|
Tocris Bioscience™
3693/50 |
50 mg |
464.00€
50mg |
Estimated Shipment: 30-01-2025
Log in to see stock. |
|||||
Description
DL-AP5 Sodium salt is the sodium salt of DL-AP5 (Cat. No. 0105) and a racemic mixture of the D- and L-isomers of AP5, a selective NMDA receptor antagonist that competes with glutamate binding and is commonly used to inhibit NMDA-dependent synaptic plasticity. D-AP5 (Cat. No. 0106) is the more active isomer and displays approximately 52-fold higher potency than the L-isomer, L-AP5 (Cat. No. 0107). In vitro D-AP5 reduces NMDA-induced depolarization of cortical neurons, with no effect on the response to L-Quisqualic acid (Cat. No. 0188) or Kainic acid (Cat. No. 0222). Following spinal injection of D-AP5, NMDA-response is rapidly reduced, with no effect seen on spontaneously active neurons.DL mixture, D-isomer and L-isomer also available.
Specifications
| >98% | |
| DL-AP5 Sodium salt | |
| 219.11 | |
| DL-AP5 Sodium salt |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title